At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
5% Topical Benzoyl Peroxide Gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Blue Light Therapy in Reducing Cutibacterium Acnes Bioburden at the Deltopectoral Interval
In Brief
A Phase 4 clinical trial evaluating 5% Topical Benzoyl Peroxide Gel and Blue Light Therapy for Acne. Completed, enrolled 60 participants across 1 site.
Detailed Summary
This proposal aims to investigate a novel light-based treatment to reduce morbidity in shoulder surgical patients. This has potential to improve outcomes and reduce health care utilization associated with infectious complications of shoulder arthroplasty. Participants will be healthy male volunteers at least 18 years of age. They will be on study for approximately 2 days.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
202120222023202420252026
First PostedMar 2020
Enrollment StartOct 2020
Primary CompletionJan 2021
TodayJul 2026
First PostedMar 9, 2020
Enrollment StartOct 5, 2020
Primary CompletionJan 22, 2021
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.3 years ago
Interventions
5% Topical Benzoyl Peroxide Geldrug
Gel treatment used to treat acne
Blue Light Therapydevice
Blue light therapy treatment for acne